Literature DB >> 15466212

Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines.

Judit P Banáth1, Susan H Macphail, Peggy L Olive.   

Abstract

Six human cervical cancer cell lines [five human papillomavirus (HPV) positive, one HPV negative] for induction and rejoining of DNA strand breaks and for kinetics of formation and loss of serine 139 phosphorylated histone H2AX (gammaH2AX). X-rays induced the same level of DNA breakage for all cell lines. By 8 hours after 20 Gy, <2% of the initial single-strand breaks remained and no double-strand breaks could be detected. In contrast, 24 hours after irradiation, gammaH2AX representing up to 30% of the initial signal still present. SW756 cells showed almost four times higher background levels of gammaH2AX and no residual gammaH2AX compared with the most radiosensitive HPV-negative C33A cells that showed the lowest background and retained 30% of the maximum level of gammaH2AX. Radiation sensitivity, measured as clonogenic-surviving fraction after 2 Gy, was correlated with the fraction of gammaH2AX remaining 24 hours after irradiation. A substantial correlation with gammaH2AX loss half-time measured over the first 4 hours was seen only when cervical cell lines were included in a larger series of p53-deficient cell lines. Interestingly, p53 wild-type cell lines consistently showed faster gammaH2AX loss half-times than p53-deficient cell lines. We conclude that cell line-dependent differences in loss of gammaH2AX after irradiation are related in part to intrinsic radiosensitivity. The possibility that the presence of gammaH2AX foci may not always signify the presence of a physical break, notably in some tumor cell lines, is also supported by these results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466212     DOI: 10.1158/0008-5472.CAN-04-1433

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  121 in total

1.  The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.

Authors:  Muhammad Jamal; Barbara H Rath; Patricia S Tsang; Kevin Camphausen; Philip J Tofilon
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

2.  A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown.

Authors:  Geoff S Higgins; Remko Prevo; Yin-Fai Lee; Thomas Helleday; Ruth J Muschel; Steve Taylor; Michio Yoshimura; Ian D Hickson; Eric J Bernhard; W Gillies McKenna
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

3.  Microenvironmental regulation of glioblastoma radioresponse.

Authors:  Muhammad Jamal; Barbara H Rath; Eli S Williams; Kevin Camphausen; Philip J Tofilon
Journal:  Clin Cancer Res       Date:  2010-10-29       Impact factor: 12.531

Review 4.  Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Authors:  Toshiki Tanaka; Xuan Huang; H Dorota Halicka; Hong Zhao; Frank Traganos; Anthony P Albino; Wei Dai; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-09       Impact factor: 4.355

5.  Functional interrogation of adult hypothalamic neurogenesis with focal radiological inhibition.

Authors:  Daniel A Lee; Juan Salvatierra; Esteban Velarde; John Wong; Eric C Ford; Seth Blackshaw
Journal:  J Vis Exp       Date:  2013-11-14       Impact factor: 1.355

6.  BRCC3 mutations in myeloid neoplasms.

Authors:  Dayong Huang; Yasunobu Nagata; Vera Grossmann; Tomas Radivoyevitch; Yusuke Okuno; Genta Nagae; Naoko Hosono; Susanne Schnittger; Masashi Sanada; Bartlomiej Przychodzen; Ayana Kon; Chantana Polprasert; Wenyi Shen; Michael J Clemente; James G Phillips; Tamara Alpermann; Kenichi Yoshida; Niroshan Nadarajah; Mikkael A Sekeres; Kevin Oakley; Nhu Nguyen; Yuichi Shiraishi; Yusuke Shiozawa; Kenichi Chiba; Hiroko Tanaka; H Phillip Koeffler; Hans-Ulrich Klein; Martin Dugas; Hiroyuki Aburatani; Satoru Miyano; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach; Yang Du; Seishi Ogawa; Hideki Makishima
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

7.  Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.

Authors:  Kenneth J Niermann; Luigi Moretti; Nicholas J Giacalone; Yunguang Sun; Stephen M Schleicher; Prapaporn Kopsombut; Lauren R Mitchell; Kwang Woon Kim; Bo Lu
Journal:  Radiat Res       Date:  2011-01-11       Impact factor: 2.841

8.  Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library.

Authors:  Brian E Lally; Geoffrey A Geiger; Steven Kridel; Alice E Arcury-Quandt; Michael E Robbins; Nancy D Kock; Kenneth Wheeler; Prakash Peddi; Alexandros Georgakilas; Gary D Kao; Constantinos Koumenis
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity.

Authors:  Toshimitsu Tanaka; Anupama Munshi; Colin Brooks; Jenny Liu; Marvette L Hobbs; Raymond E Meyn
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

10.  Residual gammaH2AX foci as an indication of lethal DNA lesions.

Authors:  Judit P Banáth; Dmitry Klokov; Susan H MacPhail; C Adriana Banuelos; Peggy L Olive
Journal:  BMC Cancer       Date:  2010-01-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.